Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducing high levels of necrosis and apoptosis in colon carcinoma cells. This regimen is also able to promote a process of Ag remodeling including up-regulation of immunotherapy targets like carcinoembryonic Ag (CEA), thymidylate synthase (TS). We have conducted a preclinical study aimed to investigate whether these drug-induced modifications would also enhance colon cancer cell immunogenicity. Several CTL lines were thus generated by in vitro stimulating human HLA-A(*)02.01(+) PBMCs, from normal donors and colon cancer patients, with autologous dendritic cells cross-primed with cell lysates of colon cancer cells untreated, irradiated, or previously...
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor recept...
Cetuximab is a human/mouse chimeric IgG1 mAb to EGFR, approved for colorectal carcinoma treatment in...
Background We have recently reported that chemotherapeutic agents in ultra low noncytotoxic concentr...
Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducin...
Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducin...
Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducin...
The possibility to combine chemo and immunotherapy for the treatment of colon cancer could represent...
We have recently described a poly-chemotherapy (GOLF) regimen that: A) is active in colon carcinoma ...
The effects of anticancer chemotherapy on antigenspecific cytotoxic T lymphocytes (CTLs) are mostly ...
Purpose Tumor cell killing by anticancer drugs may be supported by their immuno- and pharmacologic e...
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor recept...
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor recept...
Cetuximab is a human/mouse chimeric IgG1 mAb to EGFR, approved for colorectal carcinoma treatment in...
Background We have recently reported that chemotherapeutic agents in ultra low noncytotoxic concentr...
Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducin...
Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducin...
Gemcitabine, oxaliplatin, leucovorin, and 5-fluorouracil (GOLF) is a novel multidrug regimen inducin...
The possibility to combine chemo and immunotherapy for the treatment of colon cancer could represent...
We have recently described a poly-chemotherapy (GOLF) regimen that: A) is active in colon carcinoma ...
The effects of anticancer chemotherapy on antigenspecific cytotoxic T lymphocytes (CTLs) are mostly ...
Purpose Tumor cell killing by anticancer drugs may be supported by their immuno- and pharmacologic e...
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor recept...
Cetuximab is a human/mouse chimeric IgG1 monoclonal antibody (mAb) to epidermal growth factor recept...
Cetuximab is a human/mouse chimeric IgG1 mAb to EGFR, approved for colorectal carcinoma treatment in...
Background We have recently reported that chemotherapeutic agents in ultra low noncytotoxic concentr...